cPLA2 activation contributes to lysosomal defects leading to impairment of autophagy after spinal cord injury

Cell Death Dis. 2019 Jul 11;10(7):531. doi: 10.1038/s41419-019-1764-1.

Abstract

The autophagy-lysosomal pathway plays an essential role in cellular homeostasis as well as a protective function against a variety of diseases including neurodegeneration. Conversely, inhibition of autophagy, for example due to lysosomal dysfunction, can lead to pathological accumulation of dysfunctional autophagosomes and consequent neuronal cell death. We previously reported that autophagy is inhibited and contributes to neuronal cell death following spinal cord injury (SCI). In this study, we examined lysosomal function and explored the mechanism of lysosomal defects following SCI. Our data demonstrated that expression levels and processing of the lysosomal enzyme cathepsin D (CTSD) are decreased by 2 h after SCI. Enzymatic activity levels of CTSD and another lysosomal enzyme, N-acetyl-alpha-glucosaminidase, are both decreased 24 h post injury, indicating general lysosomal dysfunction. Subcellular fractionation and immunohistochemistry analysis demonstrated that this dysfunction is due to lysosomal membrane permeabilization and leakage of lysosomal contents into the cytosol. To directly assess extent and mechanisms of damage to lysosomal membranes, we performed mass spectrometry-based lipidomic analysis of lysosomes purified from SCI and control spinal cord. At 2 h post injury our data demonstrated increase in several classes of lysosophospholipids, the products of phospholipases (PLAs), as well as accumulation of PLA activators, ceramides. Phospholipase cPLA2, the main PLA species expressed in the CNS, has been previously implicated in mediation of secondary injury after SCI, but the mechanisms of its involvement remain unclear. Our data demonstrate that cPLA2 is activated within 2 h after SCI preferentially in the lysosomal fraction, where it colocalizes with lysosomal-associated membrane protein 2 in neurons. Inhibition of cPLA2 in vivo decreased lysosomal damage, restored autophagy flux, and reduced neuronal cell damage. Taken together our data implicate lysosomal defects in pathophysiology of SCI and for the first time indicate that cPLA2 activation leads to lysosomal damage causing neuronal autophagosome accumulation associated with neuronal cell death.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagosomes / drug effects
  • Autophagosomes / metabolism
  • Autophagy* / drug effects
  • Autophagy* / genetics
  • Cathepsin D / genetics
  • Cathepsin D / metabolism
  • Cell Death / drug effects
  • Cell Death / genetics
  • Lysosomal-Associated Membrane Protein 2 / metabolism
  • Lysosomes / drug effects
  • Lysosomes / enzymology
  • Lysosomes / genetics
  • Lysosomes / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neurons / drug effects
  • Neurons / enzymology
  • Neurons / metabolism
  • Phospholipases A2, Cytosolic / antagonists & inhibitors
  • Phospholipases A2, Cytosolic / genetics
  • Phospholipases A2, Cytosolic / metabolism*
  • Phospholipids / chemistry*
  • Phospholipids / metabolism
  • Sequestosome-1 Protein / genetics
  • Sequestosome-1 Protein / metabolism
  • Spinal Cord / pathology
  • Spinal Cord Injuries / genetics
  • Spinal Cord Injuries / metabolism*
  • Spinal Cord Injuries / physiopathology*
  • alpha-N-Acetylgalactosaminidase / metabolism

Substances

  • Lysosomal-Associated Membrane Protein 2
  • Phospholipids
  • Sequestosome-1 Protein
  • Sqstm1 protein, mouse
  • Phospholipases A2, Cytosolic
  • alpha-N-Acetylgalactosaminidase
  • Cathepsin D